American Journal of Medical Sciences and Medicine
ISSN (Print): 2327-6681 ISSN (Online): 2327-6657 Website: https://www.sciepub.com/journal/ajmsm Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Medical Sciences and Medicine. 2026, 14(2), 32-35
DOI: 10.12691/ajmsm-14-2-3
Open AccessArticle

Profile of Sickle Cell Disease Phenotypes among Patients Attending the National Centre for Sickle Cell Disease Control in N’Djamena, Chad

Mahamat Ahmat Abousskine1, Ahmed Agabeldour2, Alcherif Hamid Mahamat3, , Millimi Adam4, Hissen Ali Habibu1 and Younous Ibrahim Younous5

1Department of Medical Laboratory Sciences, Faculty of Human Health Sciences, King Faisal University in Chad, Chad

2Faculty of Medicine, University of Kordofan, Sudan

3Department of Biotechnology, Higher Institute of Science and Technology, Abéché, Chad

4Faculty of Human Health Sciences, King Faisal University in Chad, Chad

5Department of Life and Earth Sciences, École Normale Supérieure, Chad

Pub. Date: November 16, 2026

Cite this paper:
Mahamat Ahmat Abousskine, Ahmed Agabeldour, Alcherif Hamid Mahamat, Millimi Adam, Hissen Ali Habibu and Younous Ibrahim Younous. Profile of Sickle Cell Disease Phenotypes among Patients Attending the National Centre for Sickle Cell Disease Control in N’Djamena, Chad. American Journal of Medical Sciences and Medicine. 2026; 14(2):32-35. doi: 10.12691/ajmsm-14-2-3

Abstract

Background. Sickle cell disease is an important inherited haemoglobin disorder in sub-Saharan Africa. Facility-based data on electrophoretic profiles in Chad remain limited. Objective. To describe the distribution of haemoglobin electrophoresis profiles and selected demographic and haematological findings among individuals tested at the National Centre for Sickle Cell Disease Control in N’Djamena. Methods. We reanalysed an existing cross-sectional dataset of 208 consecutive participants from the reported November 2023–November 2025 study period. Haemoglobin profiles were recorded by capillary electrophoresis and haematological measures by automated blood count. Data were summarised descriptively. The original clinical classifications and laboratory records remain subject to author verification. Results. Among 208 records, HbSS was recorded in 173 (83.2%), HbS/β⁺-thalassaemia-compatible profile in 26 (12.5%), HbSE in four (1.9%), HbSC in one (0.5%) and HbAS in four (1.9%). Mean age among 194 records with numeric ages was 11.63 ± 8.12 years; mean haemoglobin was 6.23 ± 1.55 g/dL. Parental consanguinity was recorded in 116 (55.8%). Sex coding was unresolved in two records. Conclusion. The recorded electrophoretic profiles were predominantly HbSS. HbAS profiles must be reported as sickle cell trait rather than disease. The referral-center sample, potential effects of transfusion and absence of molecular confirmation limit genotype-level interpretation and generalizability.

Keywords:
sickle cell disease capillary electrophoresis haemoglobinopathy HbSS HbAS Chad

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008; 86(6): 480-487.
 
[2]  Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010; 376(9757): 2018-2031.
 
[3]  Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018; 4: 18010.
 
[4]  Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017; 376(16): 1561-1573.
 
[5]  Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017; 390(10091): 311-323.
 
[6]  Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of child mortality. Am J Prev Med. 2011; 41(6 Suppl 4): S398-S405.
 
[7]  Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013; 381(9861): 142-151.
 
[8]  Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, Vilchis Tella V, et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023; 10(8): e585-e599.
 
[9]  Esoh K, Wonkam-Tingang E, Wonkam A. Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care. Lancet Haematol. 2021; 8(10): e744-e755.
 
[10]  Macharia AW, Mochamah G, Uyoga S, Ndila CM, Nyutu G, Makale J, et al. The clinical epidemiology of sickle cell anemia in Africa. Am J Hematol. 2018; 93(3): 363-370.
 
[11]  Piel FB, Williams TN. Subphenotypes of sickle cell disease in Africa. Blood. 2017; 130(20): 2157-2158.
 
[12]  Morrice J, Mupfururirwa W, Chianumba RI, Amuzu EX, Kandonga D, Nembaware V, et al. Sickle cell disease in Africa: SickleInAfrica registry in Ghana, Nigeria and Tanzania. eJHaem. 2025; 6(3): e70044.
 
[13]  Asare EV, Wilson I, Benneh-Akwasi Kuma AA, Dei-Adomakoh Y, Sey F, Olayemi E, et al. Burden of sickle cell disease in Ghana: the Korle-Bu experience. Adv Hematol. 2018; 2018: 6161270.
 
[14]  Houndjahoue F, Nguele SS, Djimadoum M, Toralta J, Attimer K, Youssouf H, et al. Phenotype and epidemiological profile of children with sickle cell disease followed-up at the Mother and Child Hospital of N’Djamena. Open J Pediatr. 2016; 6(3): 237-244.
 
[15]  Awaitey DK, Akorsu EE, Allotey EA, Kwasie DA, Kwadzokpui PK, Tawiah PA, et al. Assessment of hemoglobin variants in patients receiving health care at the Ho Teaching Hospital: a three-year retrospective study. Adv Hematol. 2020; 2020: 7369731.
 
[16]  Khamees I, Ata F, Choudry H, Soliman AT, De Sanctis V, Yassin MA. Manifestations of HbSE sickle cell disease: a systematic review. J Transl Med. 2021; 19: 262.